The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
COVID-19 and Smoking
Open accessAbstract
COVID-19 is mainly a disease of the respiratory tract characterized by a severe acute respiratory syndrome; the causative agent is SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2). The virus main entrance way is through mucosal tissues: nose, mouth, upper respiratory tract, and less frequently conjunctival mucosa. Tobacco smoke exposure results in inflammatory processes in the lung, increased mucosal inflammation, expression of inflammatory cytokines and tumor necrosis factor α, increased permeability in epithelial cells, mucus overproduction, and impaired mucociliary clearance.1 Knowledge about host factors, and in particular avoidable host factors such as smoking, may be of importance in reducing viral contamination and the severity of the disease. The SARS-CoV-2 pandemic started in Wuhan, China toward the end of 2019. To the best of our knowledge and at the time of the writing of this Commentary, six published case series reported the prevalence of smoking among individuals with COVID-19 (Table 1). The study with the highest number of patients compared severe (N = 173) to nonsevere (N = 926) cases. The percent of current and former smokers were higher among the severe cases: 17% and 5%, respectively, than among the nonsevere cases (12% and 1%, respectively).2 More importantly, among those with the primary composite end point (admission to an intensive care unit, the use of mechanical ventilation, or death), the proportion of smokers was higher with than among those without this end point (26% vs. 12%).2 Another case series also showed more smokers among the severe (N = 58) than among the nonsevere (N = 82) cases.3 The single modifiable host factor associated with progression of COVID-19 pneumonia was current smoking in a multivariable logistic analysis (odds ratio = 14.3, 95% confidence interval: 1.6–25.0).4 Among those who died the number of smokers was also been found to be somewhat higher (9%, 5/54) than among survivors (6%, 9/137).5 Frequency of Smoking and Former Smoking Among COVID-19 Patients. N (%) ICU: intensive care unit. Frequency of Smoking and Former Smoking Among COVID-19 Patients. N (%) ICU: intensive care unit. Vardavas and Nikitara’s recent systematic review8 identified five studies2–6 and concluded that “smoking is most likely associated with negative progression and adverse outcomes of COVID-19.” Conversely, Lippi and Henry’s short meta-analysis reported no association of smoking status with severity of COVID-19.9 However, the number of cases in most studies to date is very low, and consequently the 95% confidence intervals very wide. These case series reports are descriptive and do not allow to draw firm conclusions about the association of severity of COVID-19 with smoking status. Underlying health conditions such as COPD, diabetes, and coronary heart disease are more prevalent among severe cases.2,5 Although these can causally be associated with smoking, the specific effect of smoking on COVID-19 severity cannot be disentangled. However, the nicotine and tobacco research and health care community cannot ignore these signals. We know that tobacco smoke exposure is a major risk factor for lung disease1 and cigarette smoking is a substantial risk factor for bacterial and viral infections.10 In addition, Middle East Respiratory Syndrome Coronavirus (MERS-CoV) that caused a small coronavirus epidemic in 2012–215 presented the same clinical features as the current COVID-19, and reports also indicated an association between smoking status and fatality rate,11 with current smoking also more frequent among cases than among controls (37% vs. 19%, odds ratio = 3.14, 95% confidence interval: 1.10–9.24, N = 146).12 MERS-CoV infection involves the dipeptidyl peptidase IV (DPP4) receptor while SARS-CoV-2 involves the ACE2 receptor (angiotensin II conversion enzyme-2 receptor). Both are abundant in mucosal epithelial cells and lung alveolar tissue and have multiple physiological functions. To infect the host, both viruses attach to its receptor: MERS-CoV to DPP4 and SARS-CoV-2 to ACE2, a probably key step for coronavirus infections. DPP4 mRNA and protein expressions are significantly higher in smokers compared with never smokers without airflow limitation and are inversely correlated with lung function.13 It has recently been reported that ACE2 gene expression is higher in ever smokers (both current and former) compared with never smokers in normal lung tissue in a sample of patients with lung adenocarcinoma, after adjustment for age, gender, and ethnicity. ACE2 gene expression was also higher in small and large airway epithelia of healthy ever smokers compared with never smokers: current smokers had the highest expression, never smokers had the lowest expression; recent former smokers (≤15 years) had higher ACE2 gene expression than nonsmokers but not long-term former smokers (>15 years).14 The similar upregulation associated with smoking of two different virus receptors observed with
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yang, Y.-B., Yan, Y.-Q., Akdis, C. A., & Gao, Y.-D. (2020) · Allergy · doi:10.1111/all.14238 · Cited by 4,004
COVID-19 and smoking: A systematic review of the evidence
Vardavas, C., & Nikitara, K. (2020) · Tobacco Induced Diseases · doi:10.18332/tid/119324 · Cited by 1,380
Liu, W., Tao, Z.-W., Wang, L., Yuan, M.-L., Liu, K., Zhou, L., Wei, S., Deng, Y., Liu, J., Liu, H.-G., et al. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000775 · Cited by 1,104
Cigarette Smoking and Infection
Arcavi, L., & Benowitz, N. L. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.20.2206 · Cited by 1,020
Strzelak, A., Ratajczak, A., Adamiec, A., & Feleszko, W. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15051033 · Cited by 619
Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19)
Lippi, G., & Henry, B. M. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.03.014 · Cited by 408
Alraddadi, B. M., Watson, J. T., Almarashi, A., Abedi, G. R., Turkistani, A., Sadran, M., Housa, A., Almazroa, M. A., Alraihan, N., Banjar, A., et al. (2016) · Emerging Infectious Diseases · doi:10.3201/eid2201.151340 · Cited by 269
Cai, G. (2020) · medRxiv · doi:10.1101/2020.02.05.20020107 · Cited by 128
Seys, L., Widagdo, W., Verhamme, F. M., KleinJan, A., Janssens, W., Joos, G., Bracke, K. R., Haagmans, B. L., & Brusselle, G. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix741 · Cited by 96
Cai, G. (2020) · Preprints.org · doi:10.20944/preprints202002.0051.v3 · Cited by 78
Nam, H., Park, J. W., Ki, M., Yeon, M., Kim, J., & Kim, S. W. (2017) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2017.02.008 · Cited by 67
Cited by
Stanton, R., To, Q. G., Khalesi, S., Williams, S. L., Alley, S. J., Thwaite, T. L., Fenning, A. S., & Vandelanotte, C. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17114065 · Cited by 1,386
Smoking is associated with COVID-19 progression: a meta-analysis
Patanavanich, R., & Glantz, S. A. (2020) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntaa082 · Cited by 765
Wang, Q. Q., Kaelber, D. C., Xu, R., & Volkow, N. D. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00880-7 · Cited by 634
An updated overview of e-cigarette impact on human health
Marques, P., Piqueras, L., & Sanz, M.-J. (2021) · Respiratory Research · doi:10.1186/s12931-021-01737-5 · Cited by 470
Simons, D., Shahab, L., Brown, J., & Perski, O. (2021) · Addiction · doi:10.1111/add.15276 · Cited by 371
Metadata
- Authors
- Berlin, I., Thomas, D., Le Faou, A.-L., & Cornuz, J.
- Venue
- Nicotine & Tobacco Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-04-03
- Volume
- 22
- Issue
- 9
- Pages
- 1650-1652
- ISSN
- 1462-2203 (ISSN-L)
- 1469-994X
- OpenAlex
- W3014352840
- Cited by
- 282
- References
- 15
- FWCI
- 7.73
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.